Delivery Order SPE2DB24D9802-SPE2DB25FJLDY
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,273.06 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, was issued without a set-aside designation. The contract represents a single delivery order fulfillment under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,613.94 by the Defense Logistics Agency on April 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,958.88 on August 21, 2025, for HUMIRA (adalimumab) pens containing 40 mg/0.4 mL. The order, with an ultimate completion date of August 22, 2025, was issued by the Defense Logistics Agency under a firm fixed-price contract type with no set-aside designation. Performance of the delivery will take place in Conshohocken, Pennsylvania. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency for HUMIRA (CF) Pen 40 mg/0.4 mls, valued at $5,315.34. The contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order represents pharmaceutical supply to support Department of Defense healthcare...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,489.92 by the Defense Logistics Agency on July 30, 2025, for the supply of HUMIRA (Adalimumab) CF Pen 40 mg/0.4 ml. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for ultimate completion by July 31, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- This is a $31,320.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the supply of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with an ultimate completion date of September 21, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $4,056.20 to DMS Pharmaceutical Group Inc. for HUMIRA (CF) Pen 40 mg/0.4 mL on July 15, 2025, with a completion date of July 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order represents a procurement of the branded immunosuppressant medication used to treat...
- The Defense Logistics Agency awarded a $9,450.05 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with an ultimate completion date of September 17, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order with place of performance in Conshohocken, Pennsylvania. This award was made without set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,437.68 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,856.31 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB25FJLDYDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $12,168.60 firm fixed-price delivery order by the Defense Logistics Agency on September 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This delivery order, with an ultimate completion date of September 8, 2025, represents a discrete purchase under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The contract was awarded without a set-aside designation, reflecting the company's competitive position as a woman-owned small business in federal pharmaceutical procurement. This delivery order supports the Defense Logistics Agency's mission to supply pharmaceutical products to military healthcare facilities nationwide. HUMIRA, a biologic immunosuppressant medication used to treat various inflammatory conditions, represents the type of specialty pharmaceutical products that DMS Pharmaceutical Group regularly distributes through its DLA contracts. The company's established role as a key supplier in the federal pharmaceutical supply chain enables rapid fulfillment of critical medical supply needs across Department of Defense healthcare sites, with performance centered at the contractor's Park Ridge, Illinois location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 9/5/25 |